NM_000218.3:c.1515-55G>A

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_000218.3(KCNQ1):​c.1515-55G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0385 in 1,373,006 control chromosomes in the GnomAD database, including 2,262 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.055 ( 401 hom., cov: 32)
Exomes 𝑓: 0.037 ( 1861 hom. )

Consequence

KCNQ1
NM_000218.3 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:2

Conservation

PhyloP100: 0.461

Publications

11 publications found
Variant links:
Genes affected
KCNQ1 (HGNC:6294): (potassium voltage-gated channel subfamily Q member 1) This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
KCNQ1 Gene-Disease associations (from GenCC):
  • long QT syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • long QT syndrome 1
    Inheritance: AD, AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • Jervell and Lange-Nielsen syndrome 1
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: PanelApp Australia, Labcorp Genetics (formerly Invitae), G2P
  • atrial fibrillation, familial, 3
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • short QT syndrome
    Inheritance: AD Classification: STRONG, SUPPORTIVE Submitted by: ClinGen, Orphanet
  • short QT syndrome type 2
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • familial atrial fibrillation
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • Jervell and Lange-Nielsen syndrome
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: NO_KNOWN Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.89).
BP6
Variant 11-2768789-G-A is Benign according to our data. Variant chr11-2768789-G-A is described in ClinVar as Benign. ClinVar VariationId is 1234116.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.198 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
KCNQ1NM_000218.3 linkc.1515-55G>A intron_variant Intron 11 of 15 ENST00000155840.12 NP_000209.2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
KCNQ1ENST00000155840.12 linkc.1515-55G>A intron_variant Intron 11 of 15 1 NM_000218.3 ENSP00000155840.2

Frequencies

GnomAD3 genomes
AF:
0.0544
AC:
8279
AN:
152096
Hom.:
398
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0992
Gnomad AMI
AF:
0.00110
Gnomad AMR
AF:
0.0322
Gnomad ASJ
AF:
0.0917
Gnomad EAS
AF:
0.208
Gnomad SAS
AF:
0.0888
Gnomad FIN
AF:
0.00386
Gnomad MID
AF:
0.0285
Gnomad NFE
AF:
0.0247
Gnomad OTH
AF:
0.0603
GnomAD4 exome
AF:
0.0365
AC:
44597
AN:
1220792
Hom.:
1861
AF XY:
0.0379
AC XY:
23484
AN XY:
619172
show subpopulations
African (AFR)
AF:
0.108
AC:
3114
AN:
28750
American (AMR)
AF:
0.0220
AC:
975
AN:
44344
Ashkenazi Jewish (ASJ)
AF:
0.0958
AC:
2361
AN:
24646
East Asian (EAS)
AF:
0.209
AC:
8066
AN:
38588
South Asian (SAS)
AF:
0.0817
AC:
6653
AN:
81430
European-Finnish (FIN)
AF:
0.00641
AC:
341
AN:
53192
Middle Eastern (MID)
AF:
0.0636
AC:
338
AN:
5312
European-Non Finnish (NFE)
AF:
0.0226
AC:
20201
AN:
892118
Other (OTH)
AF:
0.0486
AC:
2548
AN:
52412
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
2314
4628
6941
9255
11569
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
866
1732
2598
3464
4330
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0545
AC:
8298
AN:
152214
Hom.:
401
Cov.:
32
AF XY:
0.0546
AC XY:
4062
AN XY:
74420
show subpopulations
African (AFR)
AF:
0.0995
AC:
4133
AN:
41530
American (AMR)
AF:
0.0322
AC:
492
AN:
15300
Ashkenazi Jewish (ASJ)
AF:
0.0917
AC:
318
AN:
3468
East Asian (EAS)
AF:
0.208
AC:
1076
AN:
5162
South Asian (SAS)
AF:
0.0882
AC:
425
AN:
4818
European-Finnish (FIN)
AF:
0.00386
AC:
41
AN:
10618
Middle Eastern (MID)
AF:
0.0306
AC:
9
AN:
294
European-Non Finnish (NFE)
AF:
0.0246
AC:
1675
AN:
68000
Other (OTH)
AF:
0.0606
AC:
128
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
384
767
1151
1534
1918
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
100
200
300
400
500
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0353
Hom.:
55
Bravo
AF:
0.0594
Asia WGS
AF:
0.115
AC:
401
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Mar 03, 2015
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.89
CADD
Benign
0.79
DANN
Benign
0.76
PhyloP100
0.46
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2075870; hg19: chr11-2790019; COSMIC: COSV50105827; COSMIC: COSV50105827; API